Newsletter Subject

Rush to Publish? Medicare Drug Plan Lawsuit Quashed; Activity Curbs Cancer Pain

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Fri, Feb 16, 2024 09:07 PM

Email Preheader Text

Oncology Update Friday, February 16, 2024 ADVERTISEMENT Exclusives & Features BACKGROUND: The object

[MEDPAGE TODAY]( Oncology Update Friday, February 16, 2024 [Rush to Publish? Medicare Drug Plan Lawsuit Quashed; Activity Curbs Cancer Pain]( [Immunotherapy May Hold Promise for Skin Cancers After Kidney Transplant]( [Tepotinib Gains Full Approval for Metastatic NSCLC]( [Perioperative Tislelizumab Demonstrates Survival Benefit in NSCLC]( [U.S. Probes Role of Supply Chain Middlemen in Generic Shortages]( [PERSPECTIVES]( [Cancer Patients Caught in the Crosshairs of Hospital Consolidation]( ADVERTISEMENT Exclusives & Features [White House Post-Mortem: What Really Killed 5 Presidents?]( [Here Are This Year's Best Employers in Healthcare and Biotech]( [Cumulative incidence and risk factors of brain metastases in metastatic non-small cell lung cancer without baseline brain metastasis: Pooled analysis of individualized patient data from IMpower130, IMpower131, and IMpower150.]( BACKGROUND: The objective of this study was to explore the abilities of atezolizumab plus chemotherapy in preventing brain metastases (BMs) among metastatic non-small cell lung cancer (NSCLC) without... [READ MORE]( [Examining crossover and postprotocol therapies in first-line immunotherapy trials in non-small cell lung cancer (NSCLC).]( BACKGROUND: Immune checkpoint inhibitor (ICI) therapy has led to significant improvement in outcomes for patients with nononcogene-driven advanced non-small cell lung cancer (NSCLC). The rate of... [READ MORE]( [Why the 'try-everything tactic' is gaining momentum in cancer care]( Discover the potential of personalized drug testing for cancer treatment, but with caveats. Find out how this "try-everything" approach is gaining momentum [READ MORE]( [The 3-drug combination promising to treat the 2nd-most-common cancer in women]( "New triple-drug immunotherapy treatment shows promising results in shrinking or eliminating triple-negative breast cancer, with potential for wider accessibili [READ MORE]( [The demand of cancer patients to anticipate the management of undernutrition: is a nutrition prehabilitation before treatment conceivable as supportive care to improve quality of life? Argument for the NEHOTEL concept.]( Purpose: Our translational research team in nutrition and cancer works to identify changes in eating and cooking behaviors since the diagnosis. Educational tools have been standardized as supportive... [READ MORE]( [A Property of Everyday Health group]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2024-02-16&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

14/06/2024

Sent On

14/06/2024

Sent On

14/06/2024

Sent On

14/06/2024

Sent On

14/06/2024

Sent On

13/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.